Literature DB >> 22076386

Angelica sinensis suppresses human lung adenocarcinoma A549 cell metastasis by regulating MMPs/TIMPs and TGF-β1.

Min Gao1, Jun-Hong Zhang, Fu-Xiang Zhou, Cong-Hua Xie, Guang Han, Sheng-Quan Fang, Yun-Feng Zhou.   

Abstract

In this study we investigated the potential effects of Angelica sinensis on the growth and metastasis in human lung adenocarcinoma A549 cells. In vitro the Cck-8 assays showed that Angelica sinensis had weak antiproliferative effect on A549 cells only at high concentration. The cell adhesion assay showed that Angelica sinensis decreased the adhesive ability of A549 cells in a dose- and time-dependent manner. Transwell invasion and migration assay showed that Angelica sinensis reduced the invasive and migratory abilities of A549 cells in a dose-dependent manner. In vivo the animal experiments showed that Angelica sinensis suppressed lung metastasis of nude mice at high concentration. Then, we attempted to clarify the mechanisms of anti-metastatic activities of Angelica sinensis. The results showed Angelica sinensis inhibited the enzymatic activity of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9), it involved the down-regulation of the expressions of MMP-2 and MMP-9 at both the protein and mRNA levels, which may be associated with Angelica sinensis suppressing the expression of TGF-β1. It also involved the increase of the tissue inhibitors of metalloproteinases TIMP-2, but TIMP-1 decreased upon incubation of A549 cells with Angelica sinensis. The results suggest that Angelica sinensis might exert anti-growth and anti-metastasis activity against lung cancer cells through the decrease of MMP-2, MMP-9, TGF-β1 and TIMP-1 and increase of TIMP-2.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076386     DOI: 10.3892/or.2011.1527

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  Angelica Sinensis attenuates inflammatory reaction in experimental rat models having spinal cord injury.

Authors:  Jun Xu; Xiao-Qiang E; Hui-Yong Liu; Jun Tian; Jing-Long Yan
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  An Experimental Novel Study: Angelica sinensis Prevents Epidural Fibrosis in Laminectomy Rats via Downregulation of Hydroxyproline, IL-6, and TGF- β 1.

Authors:  Chao Zhang; Xiaohong Kong; Hengxing Zhou; Chang Liu; Xuechao Zhao; Xianhu Zhou; Yanhua Su; Hari S Sharma; Shiqing Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-29       Impact factor: 2.629

3.  Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular metastasis-associated behavior in gastric cancer.

Authors:  Dong Hua; Li Shen; Lan Xu; Zhi Jiang; Yinghui Zhou; Aihuan Yue; Shitao Zou; Zhihong Cheng; Shiliang Wu
Journal:  Int J Mol Med       Date:  2012-09-18       Impact factor: 4.101

4.  Phthalide Derivatives from Angelica Sinensis Decrease Hemoglobin Oxygen Affinity: A New Allosteric-Modulating Mechanism and Potential Use as 2,3-BPG Functional Substitutes.

Authors:  Wei-Ren Chen; Youqing Yu; Muhammad Zulfajri; Ping-Cheng Lin; Chia C Wang
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

Review 5.  Therapeutic Effects of Ten Commonly Used Chinese Herbs and Their Bioactive Compounds on Cancers.

Authors:  Wei Liu; Binbin Yang; Lu Yang; Jasmine Kaur; Calvin Jessop; Rushdi Fadhil; David Good; Guoying Ni; Xiaosong Liu; Tamim Mosaiab; Zhengjun Yi; Ming Q Wei
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-15       Impact factor: 2.629

6.  TIMP-1 Inhibits Apoptosis in Lung Adenocarcinoma Cells via Interaction with Bcl-2.

Authors:  Srilatha Nalluri; Sampa Ghoshal-Gupta; Ammar Kutiyanawalla; Sitaram Gayatri; Byung Rho Lee; Shahanawaz Jiwani; Amyn M Rojiani; Mumtaz V Rojiani
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

7.  The Combination of Astragalus membranaceus and Angelica sinensis Inhibits Lung Cancer and Cachexia through Its Immunomodulatory Function.

Authors:  Tsung-Han Wu; Kun-Yun Yeh; Chen-Hsu Wang; Hang Wang; Tsung-Lin Li; Yi-Lin Chan; Chang-Jer Wu
Journal:  J Oncol       Date:  2019-11-03       Impact factor: 4.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.